Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Blender Biomarkers: A BLENDER Sub-study to Evaluate the Effect of Oxygen Dose on Oxidative Stress and Organ Injury

NCT05542966 is registered in ClinicalTrials.gov with Australian and New Zealand Intensive Care Research Centre as lead sponsor.

NCT NCT05542966
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05542966 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Blender Biomarkers: A BLENDER Sub-study to Evaluate the Effect of Oxygen Dose on Oxidative Stress and Organ Injury
Lead sponsor
Australian and New Zealand Intensive Care Research Centre
Phase
Observational
Overall status
Unknown status
Start date
April 18, 2022
Completion date
December 31, 2023
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac failure, critical illness